Immundnz was founded through a British and Dutch collaboration by Dr. Masih Alam and Dr. Robert-Jan Lamers. We are located in the Netherlands and at the prestigious Alderley Park campus in Cheshire, UK, where we have an immunology laboratory to provide in vivo and in vitro based solutions. At the Alderley Park we access high-end facilities, professionals and a lively network of other life sciences companies. Laboratory work related to mass spectrometry and other analytical chemistry is carried out in the Netherlands.

Our strength is in experimental biology. We are different from other CROs because we can design and carry out experimental studies that are unconventional and beyond the scope of standard assays. We provide a range of standard and custom-made assays to biopharmaceutical researchers and professionals worldwide. We also provide in vivo solutions from within the Alderley Park site. With our experience and track record, you can rely on us as your unique partner in immunology and in vitro projects.


Immundnz has an entrepreneurial team of highly-skilled and qualified experts in immunology, biochemistry and analytical chemistry. The members have originated from a rich academic research background, bringing their experience into translation. Immundnz collaborates with many biopharma and business professionals of multinational pharmaceutical companies who have experience in preclinical and clinical drug analysis.

Dr. Masih Alam

Director and Founder

Dr. Masih Alam is co-founder of Immundnz. He has worked for over 15 years in both academic and business settings. In 2012, he founded ImmunoSYS, a biological consultancy company that provides immunological solutions to the biopharmaceuticals market.  ImmunoSYS has been working with industrial partners to develop the biologics market and standards in South Asia. Earlier in his career, Dr. Alam worked as a divisional director at the Alliance Francaise de Dhaka. He earned his PhD in immunology from the University of Manchester. His academic research in biological sciences focused on the fundamentals of immune response and autoimmunity.

Dr. Ir. Robert-Jan Lamers

Director and Founder

Dr. Ir. Robert-Jan Lamers is founder of Immundnz. He has over 15 years of experience in the biopharma and CRO industry and research organisations.  He founded the company Abundnz in 2011, which he developed into a solid analytical partner for biotech and pharma industries worldwide. He is member of the Advisory Board and Supervisory Committee of Utrecht University of Applied Sciences. Dr. Lamers is analytical chemist by training and holds a PhD from the University of Leiden.

Dr. Rawshan Choudhury

Principal Scientist, Protein & Cell Biology

Dr. Rawshan Choudhury, Principal Scientist at Immundnz, has worked in cell biology and protein research for over 15 years. She has used various human and other mammalian cells systems and molecular systems to study proteins. She has worked in numerous projects on different human disease systems to study the role of proteins in disease initiation or inhibition. She earned her PhD in cell biology and biochemistry from the University of Manchester.


Immundnz is supported by an advisory board with seasoned professionals in tissue modelling, immunology, preclinical research and drug toxicology, analytical chemistry, mathematical modelling, business and capital development and entrepreneurship.

Dr. Philip Hedge

Philip Hedge (PhD) is a bioscientist with 6 years of academic research, 24 years of experience of cancer drug discovery at AstraZeneca (AZ) and 4 years as an independent consultant to Biotech. Philip has conducted and led research across all phases of research, including new target discovery, lead generation, lead optimisation and preclinical support for compounds in clinical development.  In his 10 years as Director of Cancer Bioscience he led a group of more than 200 bioscientists in delivering the preclinical and translational science in support of the AZ Oncology portfolio. As a project leader he has led many cross functional drug discovery projects, and many collaborations with academia or Biotech. His strategic vision and drive brought many new technological and scientific innovations into the AZ organisation. He also led cross therapeutic area bioscientist development and science/technology sharing. He offers clear insight into the critical studies required to effectively evaluate target relevance in disease, identify clinical candidates and position experimental therapeutics appropriately in the clinic.

Prof. Neville Ford

Professor Neville Ford took his MA (Oxon) in 1983, an MSc (from Manchester in 1986) and a PhD in 1991 from Liverpool. He was invited to become a Fellow of the Institute of Mathematics and its Applications for services to Mathematics. He is a Fellow of the Higher Education Academy and is the founder and director of the University of Chester Mathematical Sciences Research Group. He supervises PhD students and conducts his own research, in collaboration with members of the Chester group and with researchers elsewhere in Europe. His research interests combine theory, computational simulations and modelling applications of functional differential equations in materials science, in the environmental sciences, in the biosciences, and in medicine. He has experience in mathematical analysis of immunologic cell interactions.

Prof. Julie Gough

Professor Julie Gough is a cell biologist whose research interests are in tissue engineering of mechanically sensitive connective tissues such as bone, cartilage, skeletal muscle and the intervertebral disc. Her research includes controlling cell responses at the cell-biomaterial interface by engineering defined surfaces. This includes analysis and control of cells such as osteoblasts, chondrocytes, fibroblasts, keratinocytes, myoblasts and macrophages on a variety of materials and scaffolds. Her research also involves development of scaffolds for tissue repair such as novel hydrogels and various porous and fibrous materials.

She has published over 70 papers and collaborates widely within academia and industries such as Johnson and Johnson and Smith and Nephew.

Jobs and Placement

We are always interested to meet talented people. We also offer student placement internships. If you are interested to join our company, please contact us.


Immundnz is open for partnering with universities, research organisations and biopharmaceutical industries.

We closely collaborate with our founding companies ImmunoSYS Ltd. and Abundnz B.V.